Chemical and Allied Products Plc (NGX:CAP)
Nigeria · Delayed Price · Currency is NGN 110.00
0.00 (0.00%)
At close: Nov 5, 2026
NGX:CAP Income Statement
Financials in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 48,271 | 44,855 | 36,362 | 23,890 | 19,208 | 14,208 | |
Revenue Growth | 12.29% | 23.36% | 52.20% | 24.37% | 35.20% | 60.07% |
Cost of Revenue | 28,281 | 26,247 | 22,126 | 15,131 | 11,684 | 9,650 |
Gross Profit | 19,989 | 18,608 | 14,236 | 8,759 | 7,524 | 4,558 |
Selling, General & Admin | 11,368 | 10,934 | 9,168 | 6,072 | 4,706 | 3,342 |
Other Operating Expenses | -501.65 | -472.31 | -395.27 | -486.74 | -244.74 | -134.92 |
Operating Expenses | 10,943 | 10,539 | 8,828 | 5,553 | 4,430 | 3,244 |
Operating Income | 9,046 | 8,069 | 5,408 | 3,206 | 3,095 | 1,314 |
Interest Expense | -1.45 | -1.45 | -30.13 | -155.35 | -33.55 | -7.61 |
Interest & Investment Income | 1,350 | 1,049 | 184.45 | 311.7 | 174.31 | 180.48 |
Currency Exchange Gain (Loss) | -146.93 | 20.35 | 460.32 | 369.55 | 207.46 | 76.11 |
EBT Excluding Unusual Items | 10,248 | 9,138 | 6,023 | 3,732 | 3,443 | 1,563 |
Gain (Loss) on Sale of Assets | 28.31 | - | 41.55 | 46.58 | 6.47 | 164.27 |
Asset Writedown | - | - | - | - | -5.02 | - |
Pretax Income | 10,276 | 9,138 | 6,064 | 3,779 | 3,444 | 1,727 |
Income Tax Expense | 4,073 | 3,393 | 2,257 | 1,264 | 1,068 | 604.92 |
Net Income | 6,203 | 5,745 | 3,807 | 2,515 | 2,376 | 1,123 |
Net Income to Common | 6,203 | 5,745 | 3,807 | 2,515 | 2,376 | 1,123 |
Net Income Growth | 28.01% | 50.89% | 51.40% | 5.83% | 111.67% | -8.22% |
Shares Outstanding (Basic) | 815 | 815 | 815 | 815 | 815 | 788 |
Shares Outstanding (Diluted) | 815 | 815 | 815 | 815 | 815 | 788 |
Shares Change | - | - | - | - | 3.36% | 12.61% |
EPS (Basic) | 7.61 | 7.05 | 4.67 | 3.09 | 2.92 | 1.42 |
EPS (Diluted) | 7.61 | 7.05 | 4.67 | 3.09 | 2.92 | 1.42 |
EPS Growth | 28.06% | 50.96% | 51.30% | 5.83% | 104.79% | -18.50% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 4,415 | 6,802 | 3,170 | 2,868 | 635.85 | -1,893 |
Free Cash Flow Per Share | 5.42 | 8.35 | 3.89 | 3.52 | 0.78 | -2.40 |
Dividend Per Share | 4.000 | 4.000 | 2.400 | 1.550 | 1.550 | 1.250 |
Dividend Growth | 66.67% | 66.67% | 54.84% | 0% | 24.00% | -40.48% |
Gross Margin | 41.41% | 41.48% | 39.15% | 36.66% | 39.17% | 32.08% |
Operating Margin | 18.74% | 17.99% | 14.87% | 13.42% | 16.11% | 9.25% |
Profit Margin | 12.85% | 12.81% | 10.47% | 10.53% | 12.37% | 7.90% |
Free Cash Flow Margin | 9.15% | 15.17% | 8.72% | 12.01% | 3.31% | -13.33% |
EBITDA | 9,902 | 8,822 | 6,063 | 3,625 | 3,448 | 1,539 |
EBITDA Margin | 20.51% | 19.67% | 16.68% | 15.17% | 17.95% | 10.84% |
D&A For EBITDA | 855.49 | 752.11 | 655.24 | 418.58 | 353.88 | 225.1 |
EBIT | 9,046 | 8,069 | 5,408 | 3,206 | 3,095 | 1,314 |
EBIT Margin | 18.74% | 17.99% | 14.87% | 13.42% | 16.11% | 9.25% |
Effective Tax Rate | 39.64% | 37.13% | 37.22% | 33.45% | 31.01% | 35.02% |